These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34967562)

  • 1. The Effect of Gene Mutations on Metastasis and Overall Survival in Metastatic and Nonmetastatic Colon Cancers.
    Ozdemir Y; Cag M; Colak E; Coskun N; Basgoz N; Sarici H; Kaan D; Dogan M; Deniz K; Inanc M; Ozkul Y
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3839-3846. PubMed ID: 34967562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New germline mutations in BRCA1, ATM, MUTYH, and RAD51D genes in Tuvans early-onset breast cancer patients.
    Gervas P; Molokov A; Ivanova A; Panferova Y; Kiselev A; Chernyshova A; Pisareva L; Choynzonov E; Cherdyntseva N
    Exp Oncol; 2021 Mar; 43(1):52-55. PubMed ID: 33785725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New germline BRCA2 gene variant in the Tuvinian Mongol breast cancer patients.
    Gervas P; Klyuch B; Denisov E; Kiselev A; Molokov A; Pisareva L; Malinovskaya E; Choynzonov E; Cherdyntseva N
    Mol Biol Rep; 2019 Oct; 46(5):5537-5541. PubMed ID: 31273614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.
    Pearlman R; Frankel WL; Swanson B; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Liyanarachchi S; Kalady M; Heald B; Greenwood C; Paquette I; Prues M; Draper DJ; Lindeman C; Kuebler JP; Reynolds K; Brell JM; Shaper AA; Mahesh S; Buie N; Weeman K; Shine K; Haut M; Edwards J; Bastola S; Wickham K; Khanduja KS; Zacks R; Pritchard CC; Shirts BH; Jacobson A; Allen B; de la Chapelle A; Hampel H;
    JAMA Oncol; 2017 Apr; 3(4):464-471. PubMed ID: 27978560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer.
    Rummel SK; Lovejoy L; Shriver CD; Ellsworth RE
    Breast Cancer Res Treat; 2017 Aug; 164(3):593-601. PubMed ID: 28503720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of pathogenic non-founder germline mutations in
    Maksimenko J; Irmejs A; Trofimovičs G; Bērziņa D; Skuja E; Purkalne G; Miklaševičs E; Gardovskis J
    Hered Cancer Clin Pract; 2018; 16():12. PubMed ID: 29928469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients.
    van den Broek E; Krijgsman O; Sie D; Tijssen M; Mongera S; van de Wiel MA; Belt EJ; den Uil SH; Bril H; Stockmann HB; Ylstra B; Carvalho B; Meijer GA; Fijneman RJ
    Oncotarget; 2016 Nov; 7(45):73876-73887. PubMed ID: 27729614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies.
    Yanus GA; Akhapkina TA; Ivantsov AO; Preobrazhenskaya EV; Aleksakhina SN; Bizin IV; Sokolenko AP; Mitiushkina NV; Kuligina ES; Suspitsin EN; Venina AR; Holmatov MM; Zaitseva OA; Yatsuk OS; Pashkov DV; Belyaev AM; Togo AV; Imyanitov EN; Iyevleva AG
    Clin Genet; 2018 May; 93(5):1015-1021. PubMed ID: 29406563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.
    Papp J; Kovacs ME; Matrai Z; Orosz E; Kásler M; Børresen-Dale AL; Olah E
    Fam Cancer; 2016 Jan; 15(1):85-97. PubMed ID: 26446593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
    Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
    J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
    Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
    JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing.
    Scarpitta R; Zanna I; Aretini P; Gambino G; Scatena C; Mei B; Ghilli M; Rossetti E; Roncella M; Congregati C; Bonci F; Naccarato AG; Palli D; Caligo MA
    Breast Cancer Res Treat; 2019 Dec; 178(3):557-564. PubMed ID: 31512090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between mutations and mRNA expression of APC and MUTYH genes: new insight into hereditary colorectal polyposis predisposition.
    Aceto GM; Fantini F; De Iure S; Di Nicola M; Palka G; Valanzano R; Di Gregorio P; Stigliano V; Genuardi M; Battista P; Cama A; Curia MC
    J Exp Clin Cancer Res; 2015 Oct; 34():131. PubMed ID: 26511139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of oligonucleotide probe array for full-length gene sequencing of TP53 in colon cancer.
    Takahashi Y; Ishii Y; Nagata T; Ikarashi M; Ishikawa K; Asai S
    Oncology; 2003; 64(1):54-60. PubMed ID: 12457032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancer.
    Netter J; Lehmann-Che J; Lambert J; Tallet A; Lourenco N; Soliman H; Bertheau P; Pariente B; Chirica M; Pocard M; Allez M; De The H; Gornet JM
    Bull Cancer; 2015 Feb; 102(2):117-25. PubMed ID: 25609485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.
    Schafmayer C; Buch S; Egberts JH; Franke A; Brosch M; El Sharawy A; Conring M; Koschnick M; Schwiedernoch S; Katalinic A; Kremer B; Fölsch UR; Krawczak M; Fändrich F; Schreiber S; Tepel J; Hampe J
    Int J Cancer; 2007 Aug; 121(3):555-8. PubMed ID: 17417778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
    Nielsen M; Hes FJ; Nagengast FM; Weiss MM; Mathus-Vliegen EM; Morreau H; Breuning MH; Wijnen JT; Tops CM; Vasen HF
    Clin Genet; 2007 May; 71(5):427-33. PubMed ID: 17489848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women.
    Kurian AW; Hughes E; Handorf EA; Gutin A; Allen B; Hartman AR; Hall MJ
    JCO Precis Oncol; 2017 Nov; 1():1-12. PubMed ID: 35172496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited Mutations in Women With Ovarian Carcinoma.
    Norquist BM; Harrell MI; Brady MF; Walsh T; Lee MK; Gulsuner S; Bernards SS; Casadei S; Yi Q; Burger RA; Chan JK; Davidson SA; Mannel RS; DiSilvestro PA; Lankes HA; Ramirez NC; King MC; Swisher EM; Birrer MJ
    JAMA Oncol; 2016 Apr; 2(4):482-90. PubMed ID: 26720728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent TP53 missense mutation in cancer patients of Arab descent.
    Zick A; Kadouri L; Cohen S; Frohlinger M; Hamburger T; Zvi N; Plaser M; Avital E; Breuier S; Elian F; Salah A; Goldberg Y; Peretz T
    Fam Cancer; 2017 Apr; 16(2):295-301. PubMed ID: 27866339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.